
PERIODONTAL MASTERCLASS REVIEW
Friday 9th July 2010 saw the UK’s first
Straumann “Masterclass in Periodontal
Regeneration”, held at the ITI Education
Centre in Crawley, West Sussex.
60 delegates received a day of lectures and open discussion sessions with Professor Nikos Donos, Head of periodontology at the Estman Dental Institute and Professor Anton Sculean, Head of Periodontology at the University of Berne, Switzerland.
The meeting covered a wide range of topics, including:
The audience were encouraged to participate in discussion and questioning throughout, and the delegates left at the end of the day with a detailed, up-to-date review of an evidence-based approach to periodontal regeneration.
Straumann plans to hold two further
periodontal masterclasses in 2011, one in
the North and one in the South in the UK.
Provisional dates are 29th and 30th June
2011, so pencil these dates in your diary.
Dates and venues will be confirmed in future
issues of Regenerative News.
Nanda Al-Nahi Discusses The Benefits of Straumann® Emdogain to Design Regenerate Periodontal Tissue and Significantly Improve the Outcome of Periodontal Treatment.
WHEN WERE YOU FIRST INTRODUCED TO STRAUMANN® EMDOGAIN?
As the Specialist Periodontist, I am keen to use
the latest regenerative procedures and materials
that have sound scientific research and wellrespected
clinicians supporting them. I first
used Straumann® Emdogain at Guy's Hospital,
where I trained. Since then, I have been using
it successfully in practice since 2001.
IN WHICH CLINICAL SITUATIONS IS THE USE OF STRAUMANN® EMDOGAIN ADVANTAGEOUS?
The prerequisites to using Straumann® Emdogain
are well documented in many published
articles. Careful patient selection is important,
for example, patients with good compliance,
who are well motivated with excellent plaque
control and bleeding scores that do not exceed
15%, do not smoke greater than 10 cigarettes a
day and are not compromised by uncontrolled
diabetes, bleeding disorders or serious medical
conditions which would prevent one from
performing surgery.
The teeth to be treated must have clean root surfaces. Typically, there would have been previous non-surgical therapy, but with deep pocketing remaining and evidence of infrabony defects radiographically. I tend to use Straumann® Emdogain, with consent from patients, in localised infrabony defects, around single-rooted teeth; grade 1 to early Grade 2 mandibular molar furcation defects & infrabony interdental defects (3 and 2 walled). As confirmed in the literature, it does not predictably work in upper molar furcation or suprabony defects so these sites are not suitable.
IS IT DIFFICULT TO MOTIVATE PATIENTS TO ACCEPT TREATMENT WITH STRAUMANN® EMDOGAIN?
Patients are often surprised and disappointed that they have extensive periodontitis, as it is quite insidious in nature with few or no significant
signs or symptoms until the teeth have a guarded
to poor prognosis, typically. Once the nature of
the disease, its treatment options and long-term
success rates are explained, most patients will
comply with the treatment plans recommended
as they would like to preserve their teeth for as
long as possible delaying their need for dental
implants, but without compromising their future
implant potential. Thus, when they are informed
one can regenerate a modest but significant
amount of their lost bone (usually 2-4mm), they
often prefer to have this regenerative option as
it may change the prognosis of a tooth from
fair to good.
IS STRAUMANN® EMDOGAIN FOR USE BY SPECIALISTS ONLY?
You need to be quite skilled to undertake some
of the more advanced papilla preservation
procedures and I would advise any clinician
wanting to use the product to attend one of the
many courses available.
IS THERE AN ALTERNATIVE TO STRAUMANN® EMDOGAIN?
Not really. It is relatively simple to use. The
consequences of failure of the procedure are
not catastrophic (i.e. if it fails the worst that can
happen is lake of bone fill of the defect, but the pocket may still resolve following the surgery).
The same cannot be said for other regenerative
materials on the market such as resorbable
and non-resorbabale membrance using GTR
technique and bone substitutes, which are more
technique sensitive to carry out. If a membrane
exposure or infection of the graft material occurs
due to wound breakdown when
using Straumman Emdogain because it is not a
space filler. Similar results may be achievable
with GTR but GTR is more time consuming with
potentially higher failure rates.
HOW COST EFFECTIVE IS STRAUMANN® EMDOGAIN IN TERMS OF THE RESULTS ACHIEVED?
There are costs associated with undertaking
this kind of complex treatment, but I think that
most patients accept this when they understand
the results that can be achieved in terms of
retaining teeth that have an uncertain outlook.
Also, I often get referrals from GDPs requesting
Straumann® Emdogain by name, because they
have been impressed with the results that have
been achieved.
Patients seem to be pleasantly surprised at how minimally invasive the treatment is and certainly value delaying the loss of a tooth.There is definitely an important role for Straumann® Emdogain in the world of periodontology.
For more information about Straumann® Emdogain visit www.straumann.com
|
Dr Nada Al-Nahi BDS (Lond) MSc MClinDent (Perio) FDS MRD RCS (Eng) Registered Specialist Periodontist with the GDC Practice limited to Periodontics and Implant Dentistry Clinical Director of Specialist Dental in the Guildford Nada can be contacted on: 01483 504705 or by email: info@specialistdental.co.uk |
![]() |